A sodales suspen disse vestibulum dui ultrices ferm entum a parturient scele risque potenti placerat blandit purus adipiscing eros habitasse sodales
24
Jan
Blog
23
Jan
Sociosqu scele risque aliquet penatibus pretium vesti bulum imperdiet ad metus a tempus congue a venenatis condi mentum parturient dis
23
Jan
Ut cubilia metus sagittis rhoncus non suspendisse vestibulum a taciti posuere urna scelerisque neque scelerisque condimentum sed hac sem
23
Jan
Erat sodales eget quam turpis a accumsan id metus scelerisque hac cubilia enim natoque tincidunt faucibus mollis eget elit sem eget
23
Jan
Vestibulum malesuada elit sit placerat congue viverra congue orci cras mus sociis non mi enim cum ante. Condimentum ac ac ullamcorper
09
Jan
- Marketing Authorization Application is expected to be filed in mid-2017
NEWS PROVIDED BY
Sorrento Therapeutics, Inc.
Jan 09, 2017, 09:00 ET
SAN DIEGO, Jan. 9, 2017 /PRNewswire/ -- SCILEX Pharmaceuticals Inc. ("SCILEX"), a subsidiary of Sorrento Therapeutics,...
05
Dec
- 505(b)(2) NDA resubmission is expected in mid-2017
December 5, 2016
SAN DIEGO, Dec. 5, 2016 /PRNewswire/ -- SCILEX Pharmaceuticals Inc. ("SCILEX"), a subsidiary of Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento") today announced that its pivotal study...
08
Nov
November 8, 2016
SAN DIEGO, Nov. 8, 2016 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; "Sorrento") and Scilex Pharmaceuticals Inc. ("SCILEX") announced today the closing of a transaction by which Sorrento acquired a majority of SCILEX. ...
22
Apr
MALVERN, Pa.--(BUSINESS WIRE)--SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of products focused on the treatment of pain, reported data on how healthcare providers are currently treating patients with post-herpetic neuralgia...
23
Feb
Malvern, PA, February 23, 2016 – SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of products focused on the treatment of pain, today announced the appointment of medical and regulatory affairs...